Literature DB >> 28639936

Recognition and management of antidepressant discontinuation syndrome.

Venkat Bhat1, Sidney H Kennedy1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28639936      PMCID： PMC5487275          DOI： 10.1503/jpn.170022

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  19 in total

1.  Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.

Authors:  Giovanni A Fava; Alessia Gatti; Carlotta Belaise; Jenny Guidi; Emanuela Offidani
Journal:  Psychother Psychosom       Date:  2015-02-21       Impact factor: 17.659

2.  Mirtazapine withdrawal symptoms.

Authors:  F Benazzi
Journal:  Can J Psychiatry       Date:  1998-06       Impact factor: 4.356

Review 3.  Monoamine depletion studies: implications for antidepressant discontinuation syndrome.

Authors:  Pedro L Delgado
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Authors:  Sidney H Kennedy; Raymond W Lam; Roger S McIntyre; S Valérie Tourjman; Venkat Bhat; Pierre Blier; Mehrul Hasnain; Fabrice Jollant; Anthony J Levitt; Glenda M MacQueen; Shane J McInerney; Diane McIntosh; Roumen V Milev; Daniel J Müller; Sagar V Parikh; Norma L Pearson; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

Review 5.  Neonatal venlafaxine discontinuation syndrome: A mini-review.

Authors:  Jonathon Holland; Richard Brown
Journal:  Eur J Paediatr Neurol       Date:  2016-11-25       Impact factor: 3.140

6.  A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.

Authors:  Rakesh Jain; Atul R Mahableshwarkar; Paula L Jacobsen; Yinzhong Chen; Michael E Thase
Journal:  Int J Neuropsychopharmacol       Date:  2012-09-11       Impact factor: 5.176

7.  Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Authors:  J F Rosenbaum; M Fava; S L Hoog; R C Ascroft; W B Krebs
Journal:  Biol Psychiatry       Date:  1998-07-15       Impact factor: 13.382

8.  The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.

Authors:  Aung Tint; Peter M Haddad; Ian M Anderson
Journal:  J Psychopharmacol       Date:  2008-05       Impact factor: 4.153

Review 9.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

10.  Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.

Authors:  Guy M Goodwin; Robin Emsley; Sandra Rembry; Frédéric Rouillon
Journal:  J Clin Psychiatry       Date:  2009-08-11       Impact factor: 4.384
View more
  1 in total

1.  Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial.

Authors:  Jerin Mathew; Divya Bharatkumar Adhia; Mark Llewellyn Smith; Dirk De Ridder; Ramakrishnan Mani
Journal:  Front Neurosci       Date:  2022-07-28       Impact factor: 5.152
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.